Nucleotides and AHCC Enhance Th1 Responses In Vitro in <i>Leishmania</i>-Stimulated/Infected Murine Cells

by María Auxiliadora Dea-Ayuela, Sergi Segarra, Dolores R. Serrano, Francisco Bolás-Fernández
Published 2020-08-01

Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis

by Pablo Bilbao-Ramos, Dolores R. Serrano, Helga Karina Ruiz Saldaña, Juan J. Torrado, Francisco Bolás-Fernández, María Auxiliadora Dea-Ayuela
Published 2020-03-01

(<i>E</i>)-Piplartine Isolated from <i>Piper pseudoarboreum</i>, a Lead Compound against <i>Leishmaniasis</i>

by Juan C. Ticona, Pablo Bilbao-Ramos, Ninoska Flores, M. Auxiliadora Dea-Ayuela, Francisco Bolás-Fernández, Ignacio A. Jiménez, Isabel L. Bazzocchi
Published 2020-09-01

Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis

by Adriana Bezerra-Souza, Raquel Fernandez-Garcia, Gabriela F. Rodrigues, Francisco Bolas-Fernandez, Marcia Dalastra Laurenti, Luiz Felipe Passero, Aikaterini Lalatsa, Dolores R. Serrano
Published 2019-07-01

Synthetic oxoisoaporphine alkaloids: in vitro, in vivo and in silico assessment of antileishmanial activities.

by Eduardo Sobarzo-Sánchez, Pablo Bilbao-Ramos, Maria Dea-Ayuela, Humberto González-Díaz, Matilde Yañez, Eugenio Uriarte, Lourdes Santana, Victoria Martínez-Sernández, Francisco Bolás-Fernández, Florencio M Ubeira
Published 2013-01-01